Table 1.

Correlation of Gas5 expression with clinicopathological features of patients with CRC

Clinicopathological features	N	Gas5 mRNA expression	P	Gas5 protein expression	P
Age (years)
≤ 60	79	0.59 ± 0.20	0.162	0.46 ± 0.14	0.691
> 60	47	0.54 ± 0.18		0.47 ± 0.13
Gender
Male	74	0.56 ± 0.20	0.582	0.45 ± 0.11	0.214
Female	52	0.58 ± 0.20		0.48 ± 0.16
Tumor size (cm)
≤ 5	45	0.64 ± 0.19	0.002	0.53 ± 0.15	< 0.001
> 5	81	0.53 ± 0.19		0.42 ± 0.10
Invasive depth
T1	28	0.62 ± 0.22	0.185	0.47 ± 0.14	0.053
T2	44	0.59 ± 0.18		0.50 ± 0.15
T3	35	0.54 ± 0.21		0.44 ± 0.11
T4	19	0.50 ± 0.16		0.41 ± 0.10
Lymph node metastasis
With	67	0.55 ± 0.17	0.153	0.45 ± 0.14	0.202
Without	59	0.60 ± 0.22		0.48 ± 0.12
Distant metastasis
With	80	0.55 ± 0.21	0.107	0.45 ± 0.12	0.103
Without	46	0.61 ± 0.18		0.49 ± 0.15
Tumor differentiation
Well or moderate differentiation	74	0.55 ± 0.21	0.158	0.47 ± 0.13	0.412
Poor or no differentiation	52	0.60 ± 0.18		0.45 ± 0.14
TNM staging
I–II	60	0.66 ± 0.19	< 0.001	0.49 ± 0.12	< 0.034
III–IV	66	0.49 ± 0.17		0.44 ± 0.14
Tumor site
Right hemicolon	68	0.58 ± 0.20	0.577	0.46 ± 0.15	0.684
Left hemicolon	58	0.56 ± 0.20		0.47 ± 0.12

Gas5 growth arrest-specific transcript 5, CRC colorectal cancer, TNM tumor-node-metastasis